Table 2.
The relationship between CD42b expression and clinicopathologic characteristics of patients
| Factor |
CD42b expression |
P value | |
| Negative | Positive | ||
| Age in yr | 0.157 | ||
| < 54 | 33 | 23 | |
| ≥ 54 | 26 | 31 | |
| Gender | 0.968 | ||
| Male | 26 | 24 | |
| Female | 33 | 30 | |
| Tumor location | 0.186 | ||
| Head | 31 | 35 | |
| Body, Tail | 28 | 19 | |
| Tumor grade | 0.439 | ||
| 1 | 54 | 47 | |
| 2 | 5 | 7 | |
| TNM stage | 0.556 | ||
| 1, 2 | 36 | 30 | |
| 3 | 23 | 24 | |
| Functional pNET | 1.00 | ||
| No | 56 | 52 | |
| Yes | 3 | 2 | |
| Platelet count, as × 109/L | 0.928 | ||
| < 225 | 29 | 27 | |
| ≥ 225 | 30 | 27 | |
| MPV in fL | 0.298 | ||
| < 11.1 | 32 | 24 | |
| ≥ 11.1 | 27 | 30 | |
| PLR | 0.507 | ||
| < 130.7 | 31 | 25 | |
| ≥ 130.7 | 28 | 29 | |
P < 0.05 was statistically significant. pNET: Pancreatic neuroendocrine tumor; MPV: Mean platelet volume; PLR: Platelet lymphoid ratio; TNR: Tumor, nodes, metastases.